SWM
ZBH icon

SeaCrest Wealth Management’s Zimmer Biomet ZBH Stock Holding History

SeaCrest Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,577
Closed -$602K – 704
2024
Q3 		$602K Sell
5,577
-499
-8% -$54.5K 0.06% 297
2024
Q2 		$659K Buy
6,076
+73
+1% +$8.61K 0.08% 259
2024
Q1 		$792K Sell
6,003
-685
-10% -$85.6K 0.1% 217
2023
Q4 		$802K Buy
6,688
+163
+2% +$18.2K 0.1% 214
2023
Q3 		$732K Sell
6,525
-3
-0% -$381 0.1% 222
2023
Q2 		$951K Sell
6,528
-2
-0% -$272 0.12% 176
2023
Q1 		$844K Sell
6,530
-22
-0.3% -$2.76K 0.11% 198
2022
Q4 		$835K Buy
6,552
+6
+0.1% +$696 0.12% 200
2022
Q3 		$684K Sell
6,546
-120
-2% -$13.2K 0.1% 212
2022
Q2 		$700K Buy
6,666
+237
+4% +$28.1K 0.09% 237
2022
Q1 		$822K Buy
6,429
+3,001
+88% +$362K 0.09% 220
2021
Q4 		$423K Buy
3,428
+3
+0.1% +$393 0.05% 405
2021
Q3 		$487K Sell
3,425
-1
-0% -$147 0.06% 351
2021
Q2 		$535K Buy
3,426
+2
+0.1% +$324 0.06% 322
2021
Q1 		$532K Buy
3,424
+5
+0.1% +$775 0.07% 302
2020
Q4 		$511K Buy
3,419
+8
+0.2% +$1.13K 0.07% 289
2020
Q3 		$451K Sell
3,411
-123
-3% -$16.1K 0.07% 270
2020
Q2 		$410K Sell
3,534
-94
-3% -$10.8K 0.07% 297
2020
Q1 		$356K Buy
3,628
+1
+0% +$131 0.08% 280
2019
Q4 		$527K Buy
3,627
+289
+9% +$39.9K 0.09% 271
2019
Q3 		$445K Buy
3,338
+208
+7% +$26.9K 0.08% 291
2019
Q2 		$358K Hold
3,130
– – 0.07% 334
2019
Q1 		$388K Buy
3,130
+1,572
+101% +$179K 0.07% 294
2018
Q4 		$157K Hold
1,558
– – 0.03% 498
2018
Q3 		$199K Hold
1,558
– – 0.03% 502
2018
Q2 		$169K Buy
1,558
+1
+0.1% +$109 0.03% 548
2018
Q1 		$165K Sell
1,557
-363
-19% -$42.2K 0.03% 546
2017
Q4 		$225K Buy
+1,920
New +$217K 0.04% 450

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

SeaCrest Wealth Management's ZBH Position: Q4 2024 in Review

SeaCrest Wealth Management sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 5,577 shares — an estimated $602K sold.

SeaCrest Wealth Management first reported a position in ZBH in Q4 2017 and held it in 28 quarters. The position peaked at $951K in Q2 2023. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • SeaCrest Wealth Management reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • SeaCrest Wealth Management sold 5,577 Zimmer Biomet shares in Q4 2024, an estimated $602K.
  • SeaCrest Wealth Management first reported a position in Zimmer Biomet in Q4 2017 and held it in 28 quarters.
  • SeaCrest Wealth Management's Zimmer Biomet position peaked at $951K in Q2 2023.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on SeaCrest Wealth Management's 13F filing for Q4 2024, filed 14 Jan 2025.